ColoAlert vs FIT Test: Which Bowel Cancer Test Is More Accurate?
- Chun Tang

- Jan 19
- 5 min read
ColoAlert vs FIT test: which bowel cancer test is more accurate?
If you’re trying to decide between the NHS FIT test and ColoAlert, you’ve probably seen confusing claims from both sides. The FIT test is free, widely used, and proven. ColoAlert costs more, but the makers say it’s significantly more accurate.
Both can be true. Below is a straight comparison — what each test actually does, the published accuracy figures, the cost, and which test makes sense for which person.
The short answer
The FIT test detects blood in your stool. It’s a good screening tool, but it misses many cancers that aren’t actively bleeding, and it’s less sensitive to pre-cancerous polyps.
ColoAlert detects both blood and DNA changes shed by tumours and large polyps. In peer-reviewed studies it detects significantly more colorectal cancers (around 85%) than FIT (around 60–70%), and is better at picking up advanced adenomas — the polyps that turn into cancer.
If cost is the deciding factor, do the FIT test. If accuracy matters more — particularly if you have a family history of bowel cancer, you’re symptomatic but FIT-negative, or you simply want the most thorough non-invasive screen available — ColoAlert is the better test.
What each test actually does
FIT (Faecal Immunochemical Test) - Detects: human haemoglobin (blood) in a stool sample - Sample: a small amount of stool, collected at home - Sent to: NHS lab - Result: positive or negative for blood above a defined threshold - Free in the UK every 2 years for adults aged 50–74 (the exact start age varies by nation as the NHS rolls out a lower threshold)
ColoAlert - Detects: human haemoglobin (blood) plus DNA mutations (KRAS, BRAF) and methylation markers shed by tumours and large polyps - Sample: a small amount of stool, collected at home - Sent to: an accredited lab (in the UK, distributed by Biox Medical) - Result: positive or negative, with reporting on which markers were detected - Private test, around £350–£450 depending on the provider
Accuracy — the actual numbers
This is where the difference matters. “Sensitivity” is the key word: it’s the percentage of actual cancers a test correctly identifies. The higher the sensitivity, the fewer cancers a test misses.
FIT test sensitivity (published figures vary by threshold) - Colorectal cancer: roughly 60–80% - Advanced adenomas (high-risk polyps): roughly 20–30%
ColoAlert sensitivity (from validation studies) - Colorectal cancer: roughly 85% - Advanced adenomas: roughly 40%
In plain terms: out of every 100 cancers present, FIT will pick up 60–80, and ColoAlert will pick up around 85. Out of every 100 advanced polyps present, FIT will spot 20–30 and ColoAlert will spot around 40.
Both tests are far better than nothing. Neither replaces colonoscopy, which is the gold standard and is offered on the NHS if your FIT or ColoAlert result is positive.
Where each test wins
The FIT test is the right choice when: - You’re between 50 and 74 and the NHS has invited you to screen — take it - You’re asymptomatic, average-risk, and want a free, reliable baseline screen every two years - Cost is the deciding factor
ColoAlert is worth considering when: - You have a family history of bowel cancer or polyps (and aren’t yet eligible for high-risk NHS surveillance) - You’re under 50 (the NHS programme doesn’t cover you, and bowel cancer in under-50s is rising) - You’ve had a negative FIT test but still have symptoms (bleeding, change in bowel habit, unexplained weight loss, persistent abdominal pain) - You want the most accurate non-invasive option available - You’ve been told you need a colonoscopy but want to weigh up your risk before going through the procedure
Things both tests share
Both are done at home. You don’t need to see a doctor to take the sample, though for ColoAlert you’ll register with the provider first.
Both are non-invasive. No bowel prep, no sedation, no time off work.
Both are screening tools, not diagnostic ones. A positive result means “we need to look further” — usually with a colonoscopy. A negative result means “no significant signal detected today,” not “you definitely don’t have cancer.”
Both should be repeated. Bowel cancer can develop between tests. NHS FIT is offered every 2 years. ColoAlert is typically repeated every 1–3 years depending on your risk profile.
Symptoms that should not wait for any test
Whichever test you choose, see a GP urgently if you have:
Visible blood in your stool
A persistent change in your bowel habit lasting more than 3 weeks
Unexplained weight loss
Persistent abdominal pain or a lump in your abdomen
Unexplained iron-deficiency anaemia
A strong family history of bowel cancer with new symptoms
These symptoms need a clinical assessment and possibly a colonoscopy — not a stool test in the post.
Cost and access in the UK
FIT test - Free on the NHS for eligible adults (currently 50–74, being lowered to 50 in stages across the four UK nations) - Available privately for around £30–£50 if you don’t qualify for the NHS programme
ColoAlert - Around £350–£450 in the UK, depending on the provider - Some private GP clinics include a results consultation in the price - Not currently covered by most private health insurance, though this is changing — check with your insurer - Available at Northwest Health in Preston, including a clinician-led results review
Frequently asked questions
Can I do both tests? Yes. Some people do FIT through the NHS programme and add ColoAlert if they want extra reassurance, particularly with a family history. There’s no clinical harm in doing both.
If ColoAlert is positive, what happens next? You’ll be advised to have a colonoscopy. Your private clinician can write a referral to a colorectal specialist. Depending on your situation, this can be done privately or referred back to your NHS GP.
If ColoAlert is negative, am I in the clear? For now, yes — but no screening test is perfect. Stay alert to symptoms, and repeat the test on the schedule your clinician advises (usually 1–3 years).
Is ColoAlert approved in the UK? Yes. ColoAlert is CE-marked and available in the UK through Biox Medical Ltd. It has been used in Germany and across Europe for years and is increasingly available through UK private clinics.
Why doesn’t the NHS offer ColoAlert? The NHS uses FIT because it’s cheap, well-validated for population screening, and easy to scale to millions of people. ColoAlert is more accurate but significantly more expensive per test. The NHS’s cost-effectiveness calculation favours FIT at population scale. That doesn’t mean ColoAlert isn’t worth the money for individuals.
Can I get ColoAlert through my NHS GP? No — it’s not currently available on the NHS. You’ll need to go through a private provider.
In summary
The NHS FIT test is a good screening tool and you should absolutely take it if you’re invited. But it isn’t the most accurate non-invasive test available, particularly for picking up pre-cancerous polyps.
ColoAlert detects more cancers and more high-risk polyps than FIT, at the cost of a private fee. For people with a family history, under-50s, the symptomatic-but-FIT-negative group, and anyone who wants maximum reassurance, it’s a meaningful upgrade.
The most important thing is to do a test, whichever one you can afford and access. Bowel cancer is one of the most survivable cancers when caught early — and one of the deadliest when caught late.
About the author
Dr Chun Tang (MBChB, MRCGP, MBA) is a GMC-registered private GP and co-founder of Northwest Health in Bamber Bridge, Preston. He is Medical Director of Biox Medical Ltd, the UK distributor of ColoAlert®, and brought the test to the UK after losing his father to bowel cancer. His work has been featured in The Daily Telegraph, The Mirror, BBC and GB News.
Want to discuss bowel cancer screening?Book a private GP consultation or order ColoAlert through Northwest Health.

Comments